Different interventions for post-ischaemic stroke depression in different time periods: A single-blind randomized controlled trial with stratification by time after stroke

Clinical Rehabilitation

Volumn 31, Issue 1, 2017, Pages 71-81

  Gao, Jie ^a   Lin, Meiqing ^a   Zhao, Jiuhan ^a   Bi, Siwei ^a   Ni, Ziyan ^a   Shang, Xiuli ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

antidepressive agents; Depression; psychotherapy; rehabilitation; stroke

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM;

AGED; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMPLICATION; CONTROLLED STUDY; DEPRESSIVE DISORDER; FEMALE; HUMAN; MALE; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STROKE REHABILITATION; TIME FACTOR; TREATMENT OUTCOME;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BRAIN ISCHEMIA; CITALOPRAM; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOTHERAPY; SINGLE-BLIND METHOD; STROKE; STROKE REHABILITATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 85007400007     PISSN: 02692155     EISSN: 14770873     Source Type: Journal    
DOI: 10.1177/0269215515626232     Document Type: Article

References (42)

1. Taylor-Piliae RE, Hepworth JT, Coull BM,. Predictors of depressive symptoms among community-dwelling stroke survivors. J Cardiovasc Nurs 2013; 28: 460-467.
2. Hackett ML, Anderson CS, House A, Halteh C,. Interventions for preventing depression after stroke. The Cochrane Database System Rev 2008: CD003689.
3. Hackett ML, Anderson CS, House A, Xia J,. Interventions for treating depression after stroke. The Cochrane Database System Rev 2008: CD003437.
4. Lim CM, Kim SW, Park JY, Kim C, Yoon SH, Lee JK,. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. J Neurosci Res 2009; 87: 1037-1045.
5. Shin TK, Kang MS, Lee HY, et al. Fluoxetine and sertraline attenuate postischemic brain injury in mice. Korean J Physiol Pharmacol 2009; 13: 257-263.
6. Coppell AL, Pei Q, Zetterstrom TS,. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacol 2003; 44: 903-910.
7. Russo-Neustadt AA, Beard RC, Huang YM, Cotman CW,. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 2000; 101: 305-312.
8. Anderson CS, Hackett ML, House AO,. Interventions for preventing depression after stroke. The Cochrane Database System Rev 2004: CD003689.
9. Anson K, Ponsford J,. Evaluation of a coping skills group following traumatic brain injury. Brain Inj 2006; 20: 167-178.
10. Bedard M, Felteau M, Mazmanian D, et al. Pilot evaluation of a mindfulness-based intervention to improve quality of life among individuals who sustained traumatic brain injuries. Disabil Rehabil 2003; 25: 722-731.
11. Hackett ML, Anderson CS, House AO,. Interventions for treating depression after stroke. The Cochrane Database System Rev 2004: CD003437.
12. Kneebone II, Dunmore E,. Psychological management of post-stroke depression. Br J Clin Psychol 2000; 39 (Pt 1): 53-65.
13. Kootker JA, Rasquin SM, Smits P, Geurts AC, van Heugten CM, Fasotti L,. An augmented cognitive behavioural therapy for treating post-stroke depression: Description of a treatment protocol. Clin Rehabil 2015; 29: 833-843.
14. Klausner EJ, Clarkin JF, Spielman L, Pupo C, Abrams R, Alexopoulos GS,. Late-life depression and functional disability: The role of goal-focused group psychotherapy. Int J Geriatr Psychiatry 1998; 13: 707-716.
15. Zedlitz AM, Rietveld TC, Geurts AC, Fasotti L,. Cognitive and graded activity training can alleviate persistent fatigue after stroke: A randomized, controlled trial. Stroke 2012; 43: 1046-1051.
16. Arseniou S, Arvaniti A, Samakouri M,. [Post-stroke depression: Recognition and treatment interventions]. Psychiatriki 2011; 22: 240-248.
17. Hou WH, Liang HW, Hsieh CL, Hou CY, Wen PC, Li CY,. Effects of stroke rehabilitation on incidence of poststroke depression: A population-based cohort study. J Clin Psychiatry 2013; 74: e859-866.
18. Strand T, Asplund K, Eriksson S, Hagg E, Lithner F, Wester PO,. A non-intensive stroke unit reduces functional disability and the need for long-term hospitalization. Stroke 1985; 16: 29-34.
19. Eriksson S, Asplund K, Hagg E, Lithner F, Strand T, Wester PO,. Clinical profiles of cerebrovascular disorders in a population-based patient sample. J Chronic Dis 1987; 40: 1025-1032.
20. Beck A, Steer R, Brown G,. Beck Depression Inventory Manual. San Antonio, Texas, 1996.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington: American Psychiatric Association, 1994.
22. Rampello L, Chiechio S, Nicoletti G, et al. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Psychopharmacol 2004; 173: 73-78.
23. Sondergaard MP, Jarden JO, Martiny K, Andersen G, Bech P,. Dose response to adjunctive light therapy in citalopram-treated patients with post-stroke depression. A randomised, double-blind pilot study. Psychother Psychosom 2006; 75: 244-248.
24. Bech P, Tanghoj P, Andersen HF, Overo K,. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression. Psychopharmacol 2002; 163: 20-25.
25. Lincoln NB, Flannaghan T, Sutcliffe L, Rother L,. Evaluation of cognitive behavioural treatment for depression after stroke: A pilot study. Clin Rehabil 1997; 11: 114-122.
26. Bech P, Kastrup M, Rafaelsen OJ,. Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand Suppl 1986; 326: 1-37.
27. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K,. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987; 334: 1-100.
28. Mahoney FI, Barthel DW,. Functional evaluation: The Barthel Index. MD State Med J 1965; 14: 61-65.
29. Whitlock JA Jr, Hamilton BB,. Functional outcome after rehabilitation for severe traumatic brain injury. Arch Phys Med Rehabil 1995; 76: 1103-1112.
30. Andersen G, Vestergaard K, Lauritzen L,. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994; 25: 1099-1104.
31. Parker G, Blanch B, Paterson A, et al. The superiority of antidepressant medication to cognitive behavior therapy in melancholic depressed patients: A 12-week single-blind randomized study. Acta Psychiatrica Scand 2013; 128: 271-281.
32. Mohr DC, Ho J, Duffecy J, et al. Effect of telephone-administered vs face-to-face cognitive behavioral therapy on adherence to therapy and depression outcomes among primary care patients: A randomized trial. Jama 2012; 307: 2278-2285.
33. Lauritzen L, Bendsen BB, Vilmar T, Bendsen EB, Lunde M, Bech P,. Post-stroke depression: Combined treatment with imipramine or desipramine and mianserin. A controlled clinical study. Psychopharmacol 1994; 114: 119-122.
34. Gustafson Y, Nilsson I, Mattsson M, Astrom M, Bucht G,. Epidemiology and treatment of post-stroke depression. Drugs Aging 1995; 7: 298-309.
35. Kauhanen M, Korpelainen JT, Hiltunen P, et al. Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke 1999; 30: 1875-1880.
36. Burvill P, Johnson G, Jamrozik K, Anderson C, Stewart-Wynne E,. Risk factors for post-stroke depression. Int J Geriatr Psychiatry 1997; 12: 219-226.
37. Neau JP, Ingrand P, Mouille-Brachet C, et al. Functional recovery and social outcome after cerebral infarction in young adults. Cerebrovasc Dis 1998; 8: 296-302.
38. Chen Y, Guo JJ, Zhan S, Patel NC,. Treatment effects of antidepressants in patients with post-stroke depression: A meta-analysis. Ann Pharmacother 2006; 40: 2115-2122.
39. Paolucci S, Antonucci G, Grasso MG, et al. Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study. Cerebrovasc Dis 2001; 12: 264-271.
40. Fedoroff JP, Robinson RG,. Tricyclic antidepressants in the treatment of poststroke depression. J Clin Psychiatry 1989; 50 (Suppl): 18-23; discussion 4-6.
41. Gainotti G, Antonucci G, Marra C, Paolucci S,. Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol, Neurosurg, Psychiatry 2001; 71: 258-261.
42. Lincoln NB, Flannaghan T,. Cognitive behavioral psychotherapy for depression following stroke: A randomized controlled trial. Stroke 2003; 34: 111-115.